- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.80 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x H8L: O3-methyl O5-(2-methylpropyl) 2,6-dimethyl-4-[2-(oxidanylamino)phenyl]pyridine-3,5-dicarboxylate(Non-covalent)
H8L.1: 9 residues within 4Å:- Chain A: R.198, E.238, L.239, R.281, F.282, R.284, C.285, D.288, A.289
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.239, A:L.239, A:F.282, A:F.282, A:A.289
- Hydrogen bonds: A:D.288
- Salt bridges: A:R.281
H8L.2: 9 residues within 4Å:- Chain B: R.198, E.238, L.239, R.281, F.282, R.284, C.285, D.288, A.289
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:L.239, B:L.239, B:F.282, B:F.282, B:A.289
- Hydrogen bonds: B:D.288
- Salt bridges: B:R.281
H8L.3: 9 residues within 4Å:- Chain C: R.198, E.238, L.239, R.281, F.282, R.284, C.285, D.288, A.289
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:L.239, C:L.239, C:F.282, C:F.282, C:A.289
- Hydrogen bonds: C:D.288
- Salt bridges: C:R.281
H8L.4: 9 residues within 4Å:- Chain D: R.198, E.238, L.239, R.281, F.282, R.284, C.285, D.288, A.289
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:L.239, D:L.239, D:F.282, D:F.282, D:A.289
- Hydrogen bonds: D:D.288
- Salt bridges: D:R.281
H8L.5: 9 residues within 4Å:- Chain E: R.198, E.238, L.239, R.281, F.282, R.284, C.285, D.288, A.289
7 PLIP interactions:7 interactions with chain E- Hydrophobic interactions: E:L.239, E:L.239, E:F.282, E:F.282, E:A.289
- Hydrogen bonds: E:D.288
- Salt bridges: E:R.281
H8L.6: 9 residues within 4Å:- Chain F: R.198, E.238, L.239, R.281, F.282, R.284, C.285, D.288, A.289
7 PLIP interactions:7 interactions with chain F- Hydrophobic interactions: F:L.239, F:L.239, F:F.282, F:F.282, F:A.289
- Hydrogen bonds: F:D.288
- Salt bridges: F:R.281
H8L.7: 9 residues within 4Å:- Chain G: R.198, E.238, L.239, R.281, F.282, R.284, C.285, D.288, A.289
7 PLIP interactions:7 interactions with chain G- Hydrophobic interactions: G:L.239, G:L.239, G:F.282, G:F.282, G:A.289
- Hydrogen bonds: G:D.288
- Salt bridges: G:R.281
H8L.8: 9 residues within 4Å:- Chain H: R.198, E.238, L.239, R.281, F.282, R.284, C.285, D.288, A.289
7 PLIP interactions:7 interactions with chain H- Hydrophobic interactions: H:L.239, H:L.239, H:F.282, H:F.282, H:A.289
- Hydrogen bonds: H:D.288
- Salt bridges: H:R.281
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, W.H. et al., Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate. Elife (2021)
- Release Date
- 2021-05-19
- Peptides
- NAD(+) hydrolase SARM1: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.80 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x H8L: O3-methyl O5-(2-methylpropyl) 2,6-dimethyl-4-[2-(oxidanylamino)phenyl]pyridine-3,5-dicarboxylate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, W.H. et al., Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate. Elife (2021)
- Release Date
- 2021-05-19
- Peptides
- NAD(+) hydrolase SARM1: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H